MedPath

Comparing the effectiveness of Metacognitive therapy (MCT), pharmacotherapy (SSRIs) and EEG biofeedback in Generalized Anxiety Disorders

Not Applicable
Conditions
Anxiety.
Anxiety disorder, unspecified
Registration Number
IRCT2017061233946N4
Lead Sponsor
Vice chancellor for research, Iran Univercity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

Inclusion criteria : no medicine consumption 1 month before the intervention; age 18-50 years old; having a minimum grade education.
Exclusion criteria: psychotic disorder; drug dependence.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Pretest, post test( 8 months later). Method of measurement: GAD-7 questionar.;Depression. Timepoint: Pretest, post test( 8 months later). Method of measurement: Beck Depression Inventory.
Secondary Outcome Measures
NameTimeMethod
Alpha Amplitude. Timepoint: Pretest, post test ( 8 months later). Method of measurement: Baselin by Neuroffedback.
© Copyright 2025. All Rights Reserved by MedPath